Unicycive Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VIVO CAPITAL, LLC | 02/13/2026 | 1.79 M | $10.33 M | 0.00% | 9.91% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 1.01 M | $5.86 M | 100.00% | 5.62% |
| OCTAGON CAPITAL ADVISORS LP | 02/17/2026 | 1.00 M | $5.77 M | 0.00% | 5.54% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/13/2026 | 939.20 K | $5.42 M | 0.00% | 5.20% |
| GREAT POINT PARTNERS LLC | 02/17/2026 | 796.56 K | $4.60 M | 0.00% | 4.41% |
| VANGUARD GROUP INC | 01/29/2026 | 788.59 K | $4.55 M | 19.69% | 4.37% |
| LOGOS GLOBAL MANAGEMENT LP | 02/17/2026 | 473.56 K | $2.73 M | 0.00% | 2.62% |
| CITADEL ADVISORS LLC | 02/17/2026 | 258.30 K | $1.49 M | 519.81% | 1.43% |
| CANTOR FITZGERALD, L. P. | 02/17/2026 | 200.00 K | $1.15 M | 100.00% | 1.11% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 171.29 K | $989.21 K | 36.24% | 0.95% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 99.74 K | $575.51 K | 181,249.09% | 0.55% |
| DAUNTLESS INVESTMENT GROUP, LLC | 02/17/2026 | 89.42 K | $515.93 K | 100.00% | 0.50% |
| OMERS ADMINISTRATION CORP | 02/13/2026 | 78.20 K | $451.21 K | 100.00% | 0.43% |
| STATE STREET CORP | 02/13/2026 | 65.23 K | $376.36 K | 18.97% | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 02/17/2026 | 59.99 K | $346.11 K | 0.00% | 0.33% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 55.31 K | $319.11 K | -52.86% | 0.31% |
| MORGAN STANLEY | 02/13/2026 | 46.58 K | $268.79 K | 338.97% | 0.26% |
| QUADRATURE CAPITAL LTD | 02/17/2026 | 39.11 K | $225.69 K | 100.00% | 0.22% |
| BLACKROCK, INC. | 02/12/2026 | 36.36 K | $209.77 K | 0.00% | 0.20% |
| NORTHERN TRUST CORP | 02/17/2026 | 35.94 K | $207.36 K | 9.90% | 0.20% |
| XTX TOPCO LTD | 02/17/2026 | 35.41 K | $204.29 K | -6.39% | 0.20% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 26.30 K | $151.75 K | 100.00% | 0.15% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 24.93 K | $143.85 K | 100.00% | 0.14% |
| CHICAGO PARTNERS INVESTMENT GROUP LLC | 01/28/2026 | 22.41 K | $155.10 K | -16.87% | 0.12% |
| JANE STREET GROUP, LLC | 02/12/2026 | 20.90 K | $120.59 K | 100.00% | 0.12% |
| UBS GROUP AG | 01/29/2026 | 19.91 K | $114.85 K | 265.56% | 0.11% |
| CITADEL ADVISORS LLC | 02/17/2026 | 10.90 K | $62.89 K | 100.00% | 0.06% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 1.92 K | $11.08 K | 100.00% | 0.01% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 558 | $3.22 K | -0.36% | 0.00% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 03/17/2026 | 500 | $2.89 K | 0.00% | 0.00% |
| TFC FINANCIAL MANAGEMENT, INC. | 01/23/2026 | 300 | $1.73 K | 0.00% | 0.00% |
| CITIGROUP INC | 02/13/2026 | 228 | $1.32 K | -96.59% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 152 | $877 | -81.62% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 02/09/2026 | 100 | $577 | 0.00% | 0.00% |
| BARCLAYS PLC | 02/13/2026 | 80 | $462 | 0.00% | 0.00% |
| BOGART WEALTH, LLC | 01/30/2026 | 6 | $35 | 0.00% | 0.00% |
| DANSKE BANK A/S | 02/02/2026 | 1 | $6 | 0.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 0 | $0 | -100.00% | 0.00% |
| FORTITUDE FAMILY OFFICE, LLC | 01/15/2026 | 0 | $0 | -100.00% | 0.00% |
Unicycive Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 40 institutional investors and hedge funds held shares of Unicycive Therapeutics Inc. The most heavily invested institutionals were:
Chicago Partners Investment Group LLC: 21,778
UBS Group AG: 19,444
SBI Securities Co., Ltd.: 557
TFC Financial Management, Inc.: 300
Fortitude Family Office, LLC: 75
Bogart Wealth, LLC: 6
45.08% of Unicycive Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 8.26 M shares in the last 24 months. This purchase volume represents approximately $58.24 M in transactions.